GEE analysis in responders versus non-responders during treatment (adjusted for age, gender and time cofactors).

Comparison of δ LDL-C levels between the 2 groups.

Yuichi Ozaki (695053)
Atsushi Tanaka (40313)
Tsuyoshi Nishiguchi (5504651)
Kenichi Komukai (5504663)
Akira Taruya (5504648)
Keisuke Satogami (5504645)
Manabu Kashiwagi (601932)
Akio Kuroi (5504660)
Yoshiki Matsuo (5504654)
Yasushi Ino (1895608)
Hironori Kitabata (5504642)
Takashi Kubo (1269624)
Takeshi Hozumi (5504657)
Takashi Akasaka (4233094)

July 2018

δ LDL-C levels in patients with responder group were greater than those in non-responder group (r...

Baseline characteristics of the study subjects (n = 10).

Ott Saluveer (641441)
Pia Larsson (182240)
Wilhelm Ridderstråle (641442)
Thórdís J. Hrafnkelsdóttir (641443)
Sverker Jern (182261)
Niklas Bergh (182247)

October 2014

Abbreviations: CRP = C-reactive protein, LDL = low density lipoprotein, HDL = high density lip...

Tracking of high-sensitivity c-reactive protein after an initially elevated concentration: the jupiter study

Robert J. Glynn
Jean G. Macfadyen
Paul M Ridker

January 2009

ating Rosuvastatin) trial suggests that increased high-sensitivity C-reactive protein (hsCRP) concen...

GEE analysis in responders versus non-responders during treatment (no adjust cofactor).

Kuo-Wei Yeh (487622)
Chi-Ming Lee (309334)
Chee-Jen Chang (287558)
Yu-Jr Lin (383115)
Jing-Long Huang (474060)

March 2014

*p<0.05, statistically significant.R: responders; N: non- responders; CRP = C-reactive pro...

Lipid profile and blood dynamic changes in non-responders.

Kuo-Wei Yeh (487622)
Chi-Ming Lee (309334)
Chee-Jen Chang (287558)
Yu-Jr Lin (383115)
Jing-Long Huang (474060)

March 2014

The p values were tested by paired-sample t test and nonparametric test. All the p values were te...

Summary statistics for hematological parameter among patients with objective response (CR, PR) as compared to non-responders (PD).

Monica Khunger (5896346)
Pradnya Dinkar Patil (5896349)
Arjun Khunger (5896352)
Manshi Li (5309330)
Bo Hu (126105)
Sagar Rakshit (5896355)
Arnab Basu (5896358)
Nathan Pennell (5896361)
James P. Stevenson (5896364)
Paul Elson (143703)
Tanmay S. Panchabhai (5896367)
Vamsidhar Velcheti (404806)

October 2018

Summary statistics for hematological parameter among patients with objective response (CR, PR) as co...

HG: Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States

Steven Woloshin
H. Gilbert Welch

August 2016

BACKGROUND: There is growing interest in using C-reactive protein (CRP) levels to help select patien...

Difference from baseline for clinical assessments in anti-TNF antibody responders and non-responders.

Patrick Durez (11540)
Pierre Vandepapeliere (676045)
Pedro Miranda (176149)
Antoaneta Toncheva (676046)
Alberto Berman (676047)
Tatjana Kehler (676048)
Eugenia Mociran (676049)
Bruno Fautrel (143749)
Xavier Mariette (18874)
Olivier Dhellin (676050)
Bernard Fanget (676051)
Stephane Ouary (676052)
Géraldine Grouard-Vogel (676053)
Marie-Christophe Boissier (676054)

December 2014

Post-hoc analyses: Mean changes in clinical assessments from baseline are shown at months 3, 6, a...

Non-lipid biomarker levels at time of randomization.a

Benoit J. Arsenault (677979)
Philip Barter (75857)
David A. DeMicco (677980)
Weihang Bao (677981)
Gregory M. Preston (677982)
John C. LaRosa (677983)
Scott M. Grundy (378780)
Prakash Deedwania (677984)
Heiner Greten (94823)
Nanette K. Wenger (677985)
James Shepherd (372015)
David D. Waters (677986)
John J. P. Kastelein (140832)

December 2014

Values are median (range). Atv is atorvastatin, HMW is high molecular weight, hsCRP is high-sensi...

Comparison of basic clinical data between the ACS and control groups.

Ying Tan (346135)
Ting Rong Liu (552338)
Shui Wang Hu (552339)
Di Tian (114672)
Chen Li (54018)
Jian Kai Zhong (552340)
Hai Ge Sun (552341)
Tian Tian Luo (552342)
Wen Yan Lai (552343)
Zhi-Gang Guo (552344)

April 2014

Values are means±SD. *P<0.01 compared with the control group. ACS, acute coronary syndrome...

Relationships of MCVEs to biomarker levels measured at time of randomization.a

Benoit J. Arsenault (677979)
Philip Barter (75857)
David A. DeMicco (677980)
Weihang Bao (677981)
Gregory M. Preston (677982)
John C. LaRosa (677983)
Scott M. Grundy (378780)
Prakash Deedwania (677984)
Heiner Greten (94823)
Nanette K. Wenger (677985)
James Shepherd (372015)
David D. Waters (677986)
John J. P. Kastelein (140832)

December 2014

HR is hazard ratio, CI is confidence interval, LDL is low-density lipoprotein, HDL is high-densit...

Non-response to (statin) therapy: The importance of distinguishing non-responders from non-adherers in pharmacogenetic studies

Trompet, S.
Postmus, I.
Slagboom, P. E.
Heijmans, B. T.
Smit, R. A. J.
Maier, A. B.
Buckley, Brendan M.
Sattar, N.
Stott, D. J.
Ford, I.
Westendorp, R. G. J.
de Craen, A. J. M.
Jukema, J. W.

December 2015

Purpose: In pharmacogenetic research, genetic variation in non-responders and high responders is com...

CRP values among responders and non-responders to DTH induced by candida antigen.

Brandt D. Pence (324073)
Thomas W. Lowder (324074)
K. Todd Keylock (324075)
Victoria J. Vieira Potter (324077)
Marc D. Cook (324079)
Edward McAuley (324081)
Jeffrey A. Woods (324083)

February 2013

*Significantly different compared to non-responders (p<0.05). Values are mean ± SEM.</p

Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies

Trompet, S
Postmus, I
Slagboom, PE
Heijmans, BT
Smit, RAJ
Maier, AB
Buckley, BM
Sattar, N
Stott, DJ
Ford, I
Westendorp, RGJ
de Craen, AJM
Jukema, JW

April 2016

PURPOSE: In pharmacogenetic research, genetic variation in non-responders and high responders is com...

Adjusted means and mean differences in triglyceride, HDL-cholesterol and C-reactive protein by NS-SEC and ethnic group.

Claudia Thomas (179821)
Claire M. Nightingale (168851)
Angela S. Donin (179825)
Alicja R. Rudnicka (168859)
Christopher G. Owen (168863)
Naveed Sattar (8785)
Derek G. Cook (168879)
Peter H. Whincup (168892)

March 2012

Mean: means adjusted for sex, age, observer, month and school (random effect). Missing values: CR...

Comparison of δ LDL-C levels between the 2 groups.

Yuichi Ozaki (695053)
Atsushi Tanaka (40313)
Tsuyoshi Nishiguchi (5504651)
Kenichi Komukai (5504663)
Akira Taruya (5504648)
Keisuke Satogami (5504645)
Manabu Kashiwagi (601932)
Akio Kuroi (5504660)
Yoshiki Matsuo (5504654)
Yasushi Ino (1895608)
Hironori Kitabata (5504642)
Takashi Kubo (1269624)
Takeshi Hozumi (5504657)
Takashi Akasaka (4233094)

July 2018

δ LDL-C levels in patients with responder group were greater than those in non-responder group (r...

Baseline characteristics of the study subjects (n = 10).

Ott Saluveer (641441)
Pia Larsson (182240)
Wilhelm Ridderstråle (641442)
Thórdís J. Hrafnkelsdóttir (641443)
Sverker Jern (182261)
Niklas Bergh (182247)

October 2014

Abbreviations: CRP = C-reactive protein, LDL = low density lipoprotein, HDL = high density lip...

Tracking of high-sensitivity c-reactive protein after an initially elevated concentration: the jupiter study

Robert J. Glynn
Jean G. Macfadyen
Paul M Ridker

January 2009

ating Rosuvastatin) trial suggests that increased high-sensitivity C-reactive protein (hsCRP) concen...

GEE analysis in responders versus non-responders during treatment (no adjust cofactor).

Kuo-Wei Yeh (487622)
Chi-Ming Lee (309334)
Chee-Jen Chang (287558)
Yu-Jr Lin (383115)
Jing-Long Huang (474060)

March 2014

*p<0.05, statistically significant.R: responders; N: non- responders; CRP = C-reactive pro...

Lipid profile and blood dynamic changes in non-responders.

Kuo-Wei Yeh (487622)
Chi-Ming Lee (309334)
Chee-Jen Chang (287558)
Yu-Jr Lin (383115)
Jing-Long Huang (474060)

March 2014

The p values were tested by paired-sample t test and nonparametric test. All the p values were te...

Summary statistics for hematological parameter among patients with objective response (CR, PR) as compared to non-responders (PD).

Monica Khunger (5896346)
Pradnya Dinkar Patil (5896349)
Arjun Khunger (5896352)
Manshi Li (5309330)
Bo Hu (126105)
Sagar Rakshit (5896355)
Arnab Basu (5896358)
Nathan Pennell (5896361)
James P. Stevenson (5896364)
Paul Elson (143703)
Tanmay S. Panchabhai (5896367)
Vamsidhar Velcheti (404806)

October 2018

Summary statistics for hematological parameter among patients with objective response (CR, PR) as co...

HG: Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States

Steven Woloshin
H. Gilbert Welch

August 2016

BACKGROUND: There is growing interest in using C-reactive protein (CRP) levels to help select patien...

Difference from baseline for clinical assessments in anti-TNF antibody responders and non-responders.

Patrick Durez (11540)
Pierre Vandepapeliere (676045)
Pedro Miranda (176149)
Antoaneta Toncheva (676046)
Alberto Berman (676047)
Tatjana Kehler (676048)
Eugenia Mociran (676049)
Bruno Fautrel (143749)
Xavier Mariette (18874)
Olivier Dhellin (676050)
Bernard Fanget (676051)
Stephane Ouary (676052)
Géraldine Grouard-Vogel (676053)
Marie-Christophe Boissier (676054)

December 2014

Post-hoc analyses: Mean changes in clinical assessments from baseline are shown at months 3, 6, a...

Non-lipid biomarker levels at time of randomization.a

Benoit J. Arsenault (677979)
Philip Barter (75857)
David A. DeMicco (677980)
Weihang Bao (677981)
Gregory M. Preston (677982)
John C. LaRosa (677983)
Scott M. Grundy (378780)
Prakash Deedwania (677984)
Heiner Greten (94823)
Nanette K. Wenger (677985)
James Shepherd (372015)
David D. Waters (677986)
John J. P. Kastelein (140832)

December 2014

Values are median (range). Atv is atorvastatin, HMW is high molecular weight, hsCRP is high-sensi...

Comparison of basic clinical data between the ACS and control groups.

Ying Tan (346135)
Ting Rong Liu (552338)
Shui Wang Hu (552339)
Di Tian (114672)
Chen Li (54018)
Jian Kai Zhong (552340)
Hai Ge Sun (552341)
Tian Tian Luo (552342)
Wen Yan Lai (552343)
Zhi-Gang Guo (552344)

April 2014

Values are means±SD. *P<0.01 compared with the control group. ACS, acute coronary syndrome...

Relationships of MCVEs to biomarker levels measured at time of randomization.a

Benoit J. Arsenault (677979)
Philip Barter (75857)
David A. DeMicco (677980)
Weihang Bao (677981)
Gregory M. Preston (677982)
John C. LaRosa (677983)
Scott M. Grundy (378780)
Prakash Deedwania (677984)
Heiner Greten (94823)
Nanette K. Wenger (677985)
James Shepherd (372015)
David D. Waters (677986)
John J. P. Kastelein (140832)

December 2014

HR is hazard ratio, CI is confidence interval, LDL is low-density lipoprotein, HDL is high-densit...

Non-response to (statin) therapy: The importance of distinguishing non-responders from non-adherers in pharmacogenetic studies

Trompet, S.
Postmus, I.
Slagboom, P. E.
Heijmans, B. T.
Smit, R. A. J.
Maier, A. B.
Buckley, Brendan M.
Sattar, N.
Stott, D. J.
Ford, I.
Westendorp, R. G. J.
de Craen, A. J. M.
Jukema, J. W.

December 2015

Purpose: In pharmacogenetic research, genetic variation in non-responders and high responders is com...

CRP values among responders and non-responders to DTH induced by candida antigen.

Brandt D. Pence (324073)
Thomas W. Lowder (324074)
K. Todd Keylock (324075)
Victoria J. Vieira Potter (324077)
Marc D. Cook (324079)
Edward McAuley (324081)
Jeffrey A. Woods (324083)

February 2013

*Significantly different compared to non-responders (p<0.05). Values are mean ± SEM.</p

Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies

Trompet, S
Postmus, I
Slagboom, PE
Heijmans, BT
Smit, RAJ
Maier, AB
Buckley, BM
Sattar, N
Stott, DJ
Ford, I
Westendorp, RGJ
de Craen, AJM
Jukema, JW

April 2016

PURPOSE: In pharmacogenetic research, genetic variation in non-responders and high responders is com...

Adjusted means and mean differences in triglyceride, HDL-cholesterol and C-reactive protein by NS-SEC and ethnic group.

Claudia Thomas (179821)
Claire M. Nightingale (168851)
Angela S. Donin (179825)
Alicja R. Rudnicka (168859)
Christopher G. Owen (168863)
Naveed Sattar (8785)
Derek G. Cook (168879)
Peter H. Whincup (168892)

March 2012

Mean: means adjusted for sex, age, observer, month and school (random effect). Missing values: CR...

Comparison of δ LDL-C levels between the 2 groups.

Yuichi Ozaki (695053)
Atsushi Tanaka (40313)
Tsuyoshi Nishiguchi (5504651)
Kenichi Komukai (5504663)
Akira Taruya (5504648)
Keisuke Satogami (5504645)
Manabu Kashiwagi (601932)
Akio Kuroi (5504660)
Yoshiki Matsuo (5504654)
Yasushi Ino (1895608)
Hironori Kitabata (5504642)
Takashi Kubo (1269624)
Takeshi Hozumi (5504657)
Takashi Akasaka (4233094)

July 2018

δ LDL-C levels in patients with responder group were greater than those in non-responder group (r...

Baseline characteristics of the study subjects (n = 10).

Ott Saluveer (641441)
Pia Larsson (182240)
Wilhelm Ridderstråle (641442)
Thórdís J. Hrafnkelsdóttir (641443)
Sverker Jern (182261)
Niklas Bergh (182247)

October 2014

Abbreviations: CRP = C-reactive protein, LDL = low density lipoprotein, HDL = high density lip...

Tracking of high-sensitivity c-reactive protein after an initially elevated concentration: the jupiter study

Robert J. Glynn
Jean G. Macfadyen
Paul M Ridker

January 2009

ating Rosuvastatin) trial suggests that increased high-sensitivity C-reactive protein (hsCRP) concen...

GEE analysis in responders versus non-responders during treatment (adjusted for age, gender and time cofactors).

Abstract

Extracted data

GEE analysis in responders versus non-responders during treatment (adjusted for age, gender and time cofactors).

Abstract

Extracted data

Related items

Related items